Bacterial InfectionPhase 1NCT01059890
Cerebral Antibiotics Distribution After Acute Brain Injury
A Phase 1 study testing cefotaxime, Metronidazole and Ciprofloxacin in people with Bacterial Infection and Brain Injury, run by Poitiers University Hospital at 1 site in France.
Trial summary
The aim of the study is to explore the distribution of antibiotics in the brain after an acute brain injury because brain infections treatment is still an health care problem. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Bacterial Infection, Brain Injury
- What is being tested?
- cefotaxime, Metronidazole and Ciprofloxacin
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 18 participants
- Where
- 1 siteFrance
- Study dates
- Sep 2009to Jun 2013
- Phase
- Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Acute brain injury
- Patient who receive an antibiotic for an infection or prophylaxy
- Glasgow coma score < 8
Who cannot join
- Age < 18 years old
- Pregnant woman
- HCV, HIV, HBV infection
Trial locations and contacts
1 site in 1 country.
France1 site
Poitiers University Hospital - 2 rue de la Milétrie - Réanimation chirugicale
Poitiers, 86021
About this study
The aim of the study is to explore the distribution of antibiotics in the brain after an acute brain injury because brain infections treatment is still an health care problem.
- Conditions
- Bacterial Infection, Brain Injury
- Being tested
- cefotaxime, Metronidazole, Ciprofloxacin, Fosfocine
- Medical subject headings
- Bacterial Infections, Brain Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
cefotaximeDrug
MetronidazoleDrug
CiprofloxacinDrug
FosfocineDrug
| Study group | Role | What they receive |
|---|---|---|
| Cefotaxime | Experimental | Not described Receives: Drug: cefotaxime |
| Metrodinazole | Experimental | Not described Receives: Drug: Metronidazole |
| Ciprofloxacine | Experimental | Not described Receives: Drug: Ciprofloxacin |
| Fosfocine | Experimental | Not described Receives: Drug: Fosfocine |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Feb 2010 (estimated)
- Study startSep 2009
- Primary completionJun 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bacterial InfectionStudies of the same condition, open and under way.
- More trials run by Poitiers University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Enrolment
- 18 participants (actual)
Sponsor and investigators
- Lead sponsor
- Poitiers University Hospital
- Sponsor type
- University, hospital or other
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01059890
- Sponsor's protocol ID
- A-BRAIN
- Status last verified
- Oct 2016
- First submitted
- 29 Jan 2010
- Last updated
- 11 Oct 2016
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Oct 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cerebral Antibiotics Distribution After Acute Brain Injury
- ClinicalTrials.gov ID
- NCT01059890
- Acronym / sponsor ID
- A-BRAIN
- Conditions
- Bacterial Infection, Brain Injury
- Phase
- Phase 1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 18 participants (actual)
- Lead sponsor
- Poitiers University HospitalUniversity, hospital or other
- Study start
- Sep 2009
- Primary completion
- Jun 2013 (actual)
- First posted
- 1 Feb 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study is to explore the distribution of antibiotics in the brain after an acute brain injury because brain infections treatment is still an health care problem.
Study design
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Cefotaxime | Experimental | Drug: cefotaxime |
| Metrodinazole | Experimental | Drug: Metronidazole |
| Ciprofloxacine | Experimental | Drug: Ciprofloxacin |
| Fosfocine | Experimental | Drug: Fosfocine |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Acute brain injury
- Patient who receive an antibiotic for an infection or prophylaxy
- Glasgow coma score < 8
Key exclusion criteria (3 listed)
- Age < 18 years old
- Pregnant woman
- HCV, HIV, HBV infection
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| cefotaxime | Drug | Cefotaxime |
| Metronidazole | Drug | Metrodinazole |
| Ciprofloxacin | Drug | Ciprofloxacine |
| Fosfocine | Drug | Fosfocine |
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Oct 2016.
Related trials for Bacterial Infection
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
Active, not recruitingPhase 2
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
Pneumococcal Disease
Not yet recruiting
Early Pathophysiology of Hidradenitis Suppurativa and Prediction of the Risk of Progression: a Prospective Cohort
Hidradenitis Suppurativa (HS)
RecruitingPhase 3
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
Pneumococcal Disease
RecruitingObservational study
Modeling Host-Pathogen Interaction Using Lymphoid Organoids
Staphylococcal Infections
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 1 study testing cefotaxime, Metronidazole and Ciprofloxacin in people with Bacterial Infection and Brain Injury, run by Poitiers University Hospital at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Oct 2016.